Home Privacy Archive Realtime Report

Stock Trading History of Thomas Frank E

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Thomas Frank E since year 2005. The trader's CIK number is 1242616. At the time of this reporting, Thomas Frank E is the President & CEO of Critical Therapeutics Inc (stock ticker symbol CRTX).

Stock purchases, sales, and option exercises reported by *Thomas Frank E* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-08-22	CRTX	Critical Therapeutics Inc	Purchase	5,000	2.10	10,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thomas Frank E (President & CEO of Critical Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.